Khosla Ventures Acquisition Co. announces Special Meeting of Stockholders to approve business combination with Valo Health

BOSTON and MENLO PARK, Calif., Oct. 25, 2021 /PRNewswire/ -- Khosla Ventures Acquisition Co. (Nasdaq:KVSA) ("KVSA"), a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC ("Khosla Ventures"), today announced that the Special Meeting of Stockholders ("Special Meeting") to vote on the approval and adoption of KVSA's business combination agreement with Valo Health, LLC ("Valo Health") and the wholly owned subsidiary of Valo Health, Valo Health, Inc. ("Valo"), will be held via live telecast on November 16, 2021 at 10:00 a.m. ET.  Following the business combination, Valo will be a wholly owned subsidiary of KVSA.  Valo Health is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. 

Read more at prnewswire.com